greeksoup/ stock research

Eastman Chemical Co.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 30 April 2026: press release. Guidance figures: 1 lowered, 6 new, 1 kept. The quarter’s numbers.

Key takeaways

  • Sales and adjusted EBIT fell year over year: Sales were $2,177 million versus $2,290 million. Adjusted EBIT was $200 million versus $311 million, and adjusted EPS was $1.09 versus $1.91. Source
  • Lower spreads and volumes drove EBIT decline: EBIT fell on lower Chemical Intermediates spreads, lower Fibers volume and mix, lower Advanced Materials asset utilization, and higher energy costs. Source
  • Adjusted EBIT margin rose sequentially: Adjusted EBIT margin was 9.2% versus 13.6% a year earlier. Management cited 240 basis points of sequential improvement from better volumes and price-cost management. Source
  • Operating cash used improved year over year: Cash used in operating activities was $137 million versus $167 million a year earlier. Source
  • Methanolysis ramp on track: Management said the Kingsport methanolysis facility made solid progress in commercial ramp-up and remains on track for its operational and financial goals. Source

“We delivered a solid first quarter that was in line with our expectations for both earnings and cash flow”

Mark Costa, Board Chair and CEO

Guidance

AreaPeriodFigureAgainst last quarter
Second-quarter adjusted diluted EPS Sourcesecond quarter 2026$1.70 to $1.90New
Cost reductions, net of inflation Source2026$125 million to $150 millionKept
Capital expenditures Source2026approximately $400 millionNew
Specialty price increases Sourcenot stated~$500 millionNew
Methanolysis facility earnings Sourcenot stated~$30 million of incremental earningsNew
Operating cash flow Source2026approach 2025 levelsLowered from similar to 2025
Consumer discretionary end-market demand Source2026 versus 2025stable; automotive down low-single-digitsNew
Planned maintenance costs Sourcesecond quarter 2026approximately $45 millionNew

What changed from last quarter

  • New guidance: Second-quarter 2026 adjusted diluted EPS range of $1.70 to $1.90 was given. The prior release gave a first-quarter range and no second-quarter figure. Source
  • New guidance: A 2026 capital expenditure figure of approximately $400 million was given. The prior release did not state a capital expenditure amount. Source
  • Guidance lowered: Operating cash flow was described as approaching 2025 levels, with management saying the pathway is narrowing. The prior release said similar to 2025. Source
  • New: Chemical Intermediates market conditions tightened from March after the Middle East conflict began, according to the company. Source
  • New: Price increases of about $500 million across the portfolio were announced to offset raw material and distribution inflation. Source

Quarter results and growth drivers

  • Sales and adjusted EBIT fell year over year: Sales were $2,177 million versus $2,290 million. Adjusted EBIT was $200 million versus $311 million, and adjusted EPS was $1.09 versus $1.91. Source
  • Lower spreads and volumes drove EBIT decline: EBIT fell on lower Chemical Intermediates spreads, lower Fibers volume and mix, lower Advanced Materials asset utilization, and higher energy costs. Source
  • Tariff refund partly offset costs: Continued cost-reduction initiatives and a recognized refund for tariffs paid under the International Emergency Economic Powers Act partly offset the decline in EBIT. Source
  • GAAP EPS fell to $0.93: GAAP diluted EPS was $0.93 versus $1.57. Net earnings were $107 million versus $182 million attributable to Eastman. Source

Segments and regions

  • Advanced Materials margin fell on utilization: Advanced Materials sales were $715 million versus $719 million. Adjusted EBIT was $69 million (9.7%) versus $116 million (16.1%), driven by lower asset utilization from inventory reduction. Source
  • Fibers sales and margin declined sharply: Fibers sales were $225 million versus $288 million. Adjusted EBIT was $45 million (20.0%) versus $88 million (30.6%). Source
  • Chemical Intermediates swung to a loss: Chemical Intermediates sales were $495 million versus $545 million. Adjusted EBIT was a loss of $18 million (-3.6%) versus $19 million (3.5%) on lower spreads. Source
  • Additives and Functional Products held steady: Additives & Functional Products sales were $739 million versus $733 million. Adjusted EBIT was $142 million (19.2%), unchanged from $141 million (19.2%) a year earlier. Source
  • Sales fell in most regions: United States and Canada sales were $979 million versus $1,020 million. EMEA was $574 million versus $610 million, Asia Pacific $500 million versus $539 million, and Latin America $124 million versus $121 million. Source

“the Eastman team quickly took decisive actions to secure supply for crucial raw materials, adjust prices where necessary, and partner with our customers”

Mark Costa, Board Chair and CEO

Products and customers

  • Specialty plastics growth offset films weakness: Specialty plastics grew, while performance films declined on a soft automotive aftermarket. Source
  • Coatings additives fell, pharma and aviation grew: Additives volume fell on lower coatings additives demand in building and construction and a few discontinued products, partly offset by pharma and aviation growth. Source
  • Acetate tow customers reduced shipments: Fibers volume fell as customers continued destocking acetate tow inventory, and the Middle East conflict led to some reduced customer shipments. Source

Costs, margins and pricing

  • Adjusted EBIT margin rose sequentially: Adjusted EBIT margin was 9.2% versus 13.6% a year earlier. Management cited 240 basis points of sequential improvement from better volumes and price-cost management. Source
  • Operating expenses declined year over year: Selling, general and administrative expenses were $178 million versus $182 million. Research and development expenses were $60 million versus $67 million. Source
  • Lower raw material prices reduced selling prices: Selling prices were lower, with the company attributing the decline to lower raw material prices. Source

“Compared to January, the most visible change is in Chemical Intermediates, where tightening market conditions are quickly and substantially improving margins.”

Mark Costa, Board Chair and CEO

Cash, capital and shareholder returns

  • Operating cash used improved year over year: Cash used in operating activities was $137 million versus $167 million a year earlier. Source
  • Inventory built ahead of shutdowns: Inventory rose to prepare for large, planned shutdowns in the second quarter. Inventory was an $119 million use of cash in the quarter. Source
  • Capital spending fell from prior year: Additions to properties and equipment were $103 million versus $147 million a year earlier. Source
  • Dividends of $96 million paid: Management said the company returned $96 million to stockholders through dividends. The company listed dividends, capital expenditures, and share repurchases as 2026 cash priorities. Source
  • Net debt rose from year-end: Total borrowings were $5,220 million and net debt was $4,555 million, versus $4,787 million and $4,221 million at December 31, 2025. Source

Strategy and innovation

  • Methanolysis ramp on track: Management said the Kingsport methanolysis facility made solid progress in commercial ramp-up and remains on track for its operational and financial goals. Source
  • Renew product wins expected to drive growth: Management expects meaningful growth from its innovation-driven model, led by new wins in Renew product lines made at the Kingsport methanolysis facility. Source
  • U.S. assets support customer supply: Management said it is leveraging integrated U.S.-based assets and global reach to be a reliable supplier amid a dynamic global environment. Source

Risks management discussed

  • Demand: Management said it does not know how long the Middle East conflict will last or what effect it may have on consumer demand. Source
  • External: Raw material and distribution cost increases are being offset through price increases, according to management. Source
  • Financial: Management said inflation is putting pressure on working capital. Source
  • Operational: Higher energy costs across businesses resulted from Winter Storm Fern, adding to first-quarter costs. Source
  • Demand: Performance films were affected by a soft automotive aftermarket during the quarter. Source

Earlier plans management reported on

  • Met: Management said first-quarter results were in line with its expectations for earnings and cash flow. Source
  • On track: Management said it remains on track for methanolysis operational and financial goals. Source
  • On track: Management said it remains on track for the cost-reduction target, net of inflation. Source
  • Not stated: Management said the pathway to cash flow near 2025 levels is narrowing; the prior release said similar to 2025. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.